Today: 29 April 2026

Rigetti Computing (RGTI) Stock News and Forecast Today: Quantum Hype, Government Hopes and Bubble Fears – 5 December 2025

Rigetti Computing (RGTI) Stock News and Forecast Today: Quantum Hype, Government Hopes and Bubble Fears – 5 December 2025

Rigetti Computing shares traded near $28 Friday afternoon, down from Thursday’s close of about $30 but still up sharply from earlier in the week. The stock surged over 15% Thursday on heavy volume after a 42% drop in November. Rigetti’s 12-month gain at one point neared 5,400%. Market cap now fluctuates between $9 billion and $11 billion.
5 December 2025
···
GE Vernova (GEV) Stock Today: Price, Latest News, Analyst Forecasts and Investment Outlook – December 5, 2025

GE Vernova (GEV) Stock Today: Price, Latest News, Analyst Forecasts and Investment Outlook – December 5, 2025

GE Vernova shares climbed over 4% to the $625–$630 range Wednesday, extending year-to-date gains to about 83% and lifting market value near $170 billion. The company announced new wind turbine deals in Romania and Taiwan and will host an Investor Update on December 9. Q3 results showed double-digit revenue growth and strong cash flow. The stock trades at nearly 100 times trailing earnings.
5 December 2025
·
Marvell Technology (MRVL) Stock on December 5, 2025: AI Earnings, Celestial AI Deal and Ontario Expansion Ignite 2026 Outlook

Marvell Technology (MRVL) Stock on December 5, 2025: AI Earnings, Celestial AI Deal and Ontario Expansion Ignite 2026 Outlook

Marvell Technology shares closed at $98.89 on December 5, up 0.7% after a two-week rally fueled by record Q3 AI-driven earnings and a major photonics acquisition. The stock remains about 21% below its 52-week high and is still down 11%–18% year-to-date. Q3 revenue hit $2.075 billion, up 37% year-on-year, with non-GAAP EPS of $0.76. Data center revenue surged 38% to $1.5 billion.
5 December 2025
···
Bloom Energy (BE) Stock December 2025 Outlook: AI Data Center Boom, $5B Brookfield Deal and Bubble Fears

Bloom Energy (BE) Stock December 2025 Outlook: AI Data Center Boom, $5B Brookfield Deal and Bubble Fears

Bloom Energy shares traded near $116 on Dec. 5, 2025, after surging as much as 1,000% over the past year amid heavy volatility and options activity. The rally follows a $5 billion partnership with Brookfield to supply power to AI data centers. Valuations have soared, with P/S ratios near 13–15 and trailing P/E figures off the charts. Most Wall Street price targets now sit below the current share price.
5 December 2025
·
Applied Digital (APLD) Stock on December 5, 2025: AI Factory Boom, $16 Billion+ Leases and a New Debt Rating

Applied Digital (APLD) Stock on December 5, 2025: AI Factory Boom, $16 Billion+ Leases and a New Debt Rating

Fitch assigned a ‘BB-’ rating to senior secured notes issued by an Applied Digital subsidiary, citing both growth and credit risk. Applied Digital shares traded around $30.56 on December 5, up over 200% year-to-date, with market cap near $9 billion and a beta close to 7. The company holds $16 billion in long-term AI data-center contracts.
5 December 2025
···
Oklo (OKLO) Stock on December 5, 2025: AI‑Fueled Nuclear Bet Faces $1.5B Dilution and Mixed Forecasts

Oklo (OKLO) Stock on December 5, 2025: AI‑Fueled Nuclear Bet Faces $1.5B Dilution and Mixed Forecasts

Oklo shares fell on December 5, 2025, after the company announced plans to sell up to $1.5 billion in new stock, raising dilution concerns. The drop followed a sharp rally sparked by Nvidia CEO Jensen Huang’s endorsement of small nuclear reactors for AI data centers. Oklo’s stock remains up over 300% in 2025, with a market cap near $16.5 billion, despite having no commercial reactors in service.
5 December 2025
·
Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025

Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025

Biomea Fusion shares rose over 10% Friday after the company reported 52-week Phase II data showing its experimental diabetes drug icovamenib sustained HbA1c reductions months after treatment ended. The results, presented at WCIRDC in Los Angeles, included no serious treatment-related adverse events. Despite the gain, Biomea’s stock remains down about 80% over the past year.
5 December 2025
··
Sandisk (SNDK) Stock on December 5, 2025: AI Flash Star, S&P 500 Debut and a New Wave of Analyst Targets

Sandisk (SNDK) Stock on December 5, 2025: AI Flash Star, S&P 500 Debut and a New Wave of Analyst Targets

Sandisk shares closed at $216.66 on December 5, up 1.6%, after surging nearly 500% year-to-date following its February spinoff from Western Digital. The company joined the S&P 500 in late November. China Renaissance initiated coverage with a Buy rating and a $322 price target the same day. Market capitalization stands just over $31 billion.
5 December 2025
···
UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth shares traded at $332–$334 on December 5, 2025, rebounding from May lows in the $230s after a year marked by a DOJ probe and a major data breach. The stock remains about 45% below its December 2024 high near $610. Analysts estimate 2025 EPS at $16.29, down 41% from the prior year. Simply Wall St values UNH at $847 per share, suggesting a 60% discount to intrinsic value.
5 December 2025
··
Robinhood (HOOD) Stock Today: Prediction Markets Push, Crypto Volatility and Wall Street Targets – December 5, 2025 Update

Robinhood (HOOD) Stock Today: Prediction Markets Push, Crypto Volatility and Wall Street Targets – December 5, 2025 Update

Robinhood shares traded near $133 midday December 5, down 3%, with a market cap of about $120 billion. The stock remains up over 200% in 2025, despite recent volatility. Needham reiterated a Buy rating and $145 target, following several analyst target hikes in November. Recent 13F filings show institutions including M&T Bank and Schroders increasing stakes.
5 December 2025
·
Argan, Inc. (AGX) Stock Plunges After Record-Backlog Q3: What Today’s Selloff Means for Investors

Argan, Inc. (AGX) Stock Plunges After Record-Backlog Q3: What Today’s Selloff Means for Investors

Argan, Inc. shares plunged about 15% to $302 in Friday morning trading after Q3 fiscal 2026 results showed an EPS beat but missed revenue estimates. The company reported record backlog near $3.0 billion and improved margins, but analysts downgraded the stock and insiders sold over $29 million in shares in the past 90 days. Argan holds no debt and $727 million in cash.
5 December 2025
·
Walmart (WMT) Stock Near Record High Ahead of Nasdaq Move and CEO Change – All the Latest News and 2026 Forecasts

Walmart (WMT) Stock Near Record High Ahead of Nasdaq Move and CEO Change – All the Latest News and 2026 Forecasts

Walmart shares traded near $115.66 Friday afternoon, approaching record highs after strong Q3 FY26 earnings and raised 2026 guidance. The stock is up 27% year to date, giving the company a market value above $900 billion. Revenue for the quarter reached $179.5 billion, up 5.8% from a year ago. Walmart will soon move to the Nasdaq and undergo a CEO transition.
5 December 2025
·
Bank of Canada Rate Cuts Are Likely Over: What a 2.25% Policy Rate Means for Mortgages, Housing and TSX Mid‑Cap Stocks

Bank of Canada Rate Cuts Are Likely Over: What a 2.25% Policy Rate Means for Mortgages, Housing and TSX Mid‑Cap Stocks

The Bank of Canada is expected to hold its policy rate at 2.25% on December 10, after 275 basis points of cuts since the start of its easing cycle. A Reuters poll of 33 economists shows no further cuts are likely until at least 2027. Unemployment fell to 6.5% in November, the lowest in 16 months. Variable mortgage rates are seen staying steady as affordability improves from 2022–23 peaks.
5 December 2025
···
Costco Stock (COST) on December 5, 2025: Sales Strength, Slowing U.S. Momentum, Board Shake-Up and 2026–2030 Forecasts

Costco Stock (COST) on December 5, 2025: Sales Strength, Slowing U.S. Momentum, Board Shake-Up and 2026–2030 Forecasts

Costco shares traded around $904 Friday afternoon, down 2.2% for 2025 after a 3% drop Thursday and lagging the S&P 500. November net sales rose 8.1% to $23.64 billion, but U.S. comparable sales growth slowed to 5.8% from 6.7% in October. Digital sales climbed about 16–17%. Investors remain wary of slowing U.S. momentum and Costco’s high valuation.
5 December 2025
1 … 1,342 1,343 1,344 1,345 1,346 … 1,879

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:57 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop